Stockreport

Zafgen Provides Update on Investigational New Drug Application for ZGN-1061

ZAFGEN INC  (ZFGN) 
Last zafgen inc earnings: 3/5 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: zafgen.gcs-web.com/investor-relations
PDF BOSTON, Nov. 26, 2018 (GLOBE NEWSWIRE) -- Zafgen, Inc. (Nasdaq:ZFGN), a clinical-stage biopharmaceutical company leveraging its proprietary knowledge of MetAP2 systems [Read more]